Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Belatacept and Risk of PTLD in US Renal Transplant Recipients

Trial Profile

Belatacept and Risk of PTLD in US Renal Transplant Recipients

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Jul 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Belatacept (Primary) ; Calcineurin inhibitors
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 20 Jul 2022 Status changed from active, no longer recruiting to completed.
    • 03 Jun 2020 Results (n=1737) assessing patterns of belatacept use and incidence of PTLD in kidney transplant recipients in clinical practice using data from OPTN database(UNOS) from two clinical studies (NCT01656343 and a US-based observational study) presented at the 2020 American Transplant Congress
    • 26 Mar 2018 Planned End Date changed from 30 Jun 2018 to 30 Jun 2019.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top